Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 323

1.

Pembrolizumab in lung cancer: current evidence and future perspectives.

Palumbo G, Carillio G, Manzo A, Montanino A, Sforza V, Costanzo R, Sandomenico C, Manna C, Luca G, Piccirillo MC, Daniele G, Cecio R, Botti G, Totaro G, Muto P, Picone C, Esposito G, Normanno N, Morabito A.

Future Oncol. 2019 Aug 21. doi: 10.2217/fon-2019-0073. [Epub ahead of print]

PMID:
31432705
2.

New paradigm for stage III melanoma: from surgery to adjuvant treatment.

Ascierto PA, Borgognoni L, Botti G, Guida M, Marchetti P, Mocellin S, Muto P, Palmieri G, Patuzzo R, Quaglino P, Stanganelli I.

J Transl Med. 2019 Aug 14;17(1):266. doi: 10.1186/s12967-019-2012-2. Review.

3.

Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanisms.

Giudice A, Barbieri A, Bimonte S, Cascella M, Cuomo A, Crispo A, D'Arena G, Galdiero M, Della Pepa ME, Botti G, Caraglia M, Capunzo M, Arra C, Montella M.

Onco Targets Ther. 2019 Jun 24;12:4937-4953. doi: 10.2147/OTT.S183192. eCollection 2019. Review.

4.

Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.

Casula M, Paliogiannis P, Ayala F, De Giorgi V, Stanganelli I, Mandalà M, Colombino M, Manca A, Sini MC, Caracò C, Ascierto PA, Satta RR; Melanoma Unit of Sassari (MUS), Lissia A, Cossu A, Palmieri G; Italian Melanoma Intergroup (IMI).

BMC Cancer. 2019 Aug 5;19(1):772. doi: 10.1186/s12885-019-5984-7.

5.

Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.

De Vincenzo A, Belli S, Franco P, Telesca M, Iaccarino I, Botti G, Carriero MV, Ranson M, Stoppelli MP.

Int J Cancer. 2019 Aug 5. doi: 10.1002/ijc.32613. [Epub ahead of print]

PMID:
31381136
6.

Developmental Gene Markers in Tumor Pathogenesis and Progression.

Cantile M, Palmieri G, Botti G.

Dis Markers. 2019 Jul 8;2019:5462562. doi: 10.1155/2019/5462562. eCollection 2019. No abstract available.

7.

The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth.

Di Somma S, Iannuzzi CA, Passaro C, Forte IM, Iannone R, Gigantino V, Indovina P, Botti G, Giordano A, Formisano P, Portella G, Malfitano AM, Pentimalli F.

Front Oncol. 2019 Jul 12;9:564. doi: 10.3389/fonc.2019.00564. eCollection 2019.

8.

Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.

Granata V, Fusco R, de Lutio di Castelguidone E, Avallone A, Palaia R, Delrio P, Tatangelo F, Botti G, Grassi R, Izzo F, Petrillo A.

BMC Gastroenterol. 2019 Jul 24;19(1):129. doi: 10.1186/s12876-019-1036-7.

9.

CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.

Ieranò C, D'Alterio C, Giarra S, Napolitano M, Rea G, Portella L, Santagata A, Trotta AM, Barbieri A, Campani V, Luciano A, Arra C, Anniciello AM, Botti G, Mayol L, De Rosa G, Pacelli R, Scala S.

Cell Death Dis. 2019 Jul 22;10(8):562. doi: 10.1038/s41419-019-1796-6.

10.

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy).

Ascierto PA, Agarwala SS, Botti G, Budillon A, Davies MA, Dummer R, Ernstoff M, Ferrone S, Formenti S, Gajewski TF, Garbe C, Hamid O, Lo RS, Luke JJ, Michielin O, Palmieri G, Zitvogel L, Marincola FM, Masucci G, Caracò C, Thurin M, Puzanov I.

J Transl Med. 2019 Jul 22;17(1):234. doi: 10.1186/s12967-019-1979-z.

11.

LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer.

Collina F, Aquino G, Brogna M, Cipolletta S, Buonfanti G, De Laurentiis M, Di Bonito M, Cantile M, Botti G.

J Cancer. 2019 May 12;10(9):2018-2024. doi: 10.7150/jca.29670. eCollection 2019.

12.

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.

Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori G, Di Gennaro F, Pezzullo L, Losito NS, Vecchio G, Botti G, Melillo RM, Franco R.

Cancers (Basel). 2019 Jun 7;11(6). pii: E785. doi: 10.3390/cancers11060785.

13.

Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective.

Ombra MN, Paliogiannis P, Stucci LS, Colombino M, Casula M, Sini MC, Manca A, Palomba G, Stanganelli I, Mandalà M, Gandini S, Lissia A, Doneddu V, Cossu A, Palmieri G; Italian Melanoma Intergroup (IMI).

Nutr Metab (Lond). 2019 May 21;16:33. doi: 10.1186/s12986-019-0365-4. eCollection 2019. Review.

14.

Paralogous HOX13 Genes in Human Cancers.

Botti G, Cillo C, De Cecio R, Malzone MG, Cantile M.

Cancers (Basel). 2019 May 20;11(5). pii: E699. doi: 10.3390/cancers11050699. Review.

15.

Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma.

Harder N, Schönmeyer R, Nekolla K, Meier A, Brieu N, Vanegas C, Madonna G, Capone M, Botti G, Ascierto PA, Schmidt G.

Sci Rep. 2019 May 15;9(1):7449. doi: 10.1038/s41598-019-43525-8.

16.

LncRNA HOTAIR in Tumor Microenvironment: What Role?

Botti G, Scognamiglio G, Aquino G, Liguori G, Cantile M.

Int J Mol Sci. 2019 May 8;20(9). pii: E2279. doi: 10.3390/ijms20092279. Review.

17.

Oral lichen planus and other confounding factors in narrow band imaging (NBI) during routine inspection of oral cavity for early detection of oral squamous cell carcinoma: a retrospective pilot study.

Guida A, Maglione M, Crispo A, Perri F, Villano S, Pavone E, Aversa C, Longo F, Feroce F, Botti G, Ionna F.

BMC Oral Health. 2019 Apr 30;19(1):70. doi: 10.1186/s12903-019-0762-0.

18.

Noncoding RNAs as circulating biomarkers in osteosarcoma patients.

Botti G, Giordano A, Feroce F, De Chiara AR, Cantile M.

J Cell Physiol. 2019 Nov;234(11):19249-19255. doi: 10.1002/jcp.28744. Epub 2019 Apr 29. Review.

PMID:
31032924
19.

Correction: Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern Italy.

Petruzziello A, Sabatino R, Loquercio G, Guzzo A, Di Capua L, Labonia F, Cozzolino A, Azzaro R, Botti G.

PLoS One. 2019 Apr 12;14(4):e0215559. doi: 10.1371/journal.pone.0215559. eCollection 2019.

20.

Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells.

Barbarisi M, Barbarisi A, De Sena G, Armenia E, Aurilio C, Libutti M, Iaffaioli RV, Botti G, Maurea N, Quagliariello V.

Phytother Res. 2019 Jun;33(6):1670-1682. doi: 10.1002/ptr.6354. Epub 2019 Mar 28.

PMID:
30924205

Supplemental Content

Loading ...
Support Center